Comparative Study
FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function
Affiliations
- PMID: 1721408
Item in Clipboard
Comparative Study
FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function
Transplant Proc.
1991 Dec.
No abstract available
Similar articles
-
[Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin].Nephrologie. 1992;13(3):137. Nephrologie. 1992. PMID: 1379348 Review. French. No abstract available.
-
Effect of immunosuppressive drugs (CsA, FK 506, rapamycin) on the kidney microsomal cytochrome P-450 system in the rat.Transplant Proc. 1994 Oct;26(5):2890. Transplant Proc. 1994. PMID: 7524223 No abstract available.
-
In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use.Transplant Proc. 1991 Dec;23(6):2722-4. Transplant Proc. 1991. PMID: 1721257 Review. No abstract available.
-
Effects of the immunosuppressive macrolides rapamycin and FK 506 in high responder rats presensitized to major histocompatibility complex antigens.Transplant Proc. 1993 Feb;25(1 Pt 1):673-4. Transplant Proc. 1993. PMID: 7679837 No abstract available.
-
FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line.Transplant Proc. 1991 Dec;23(6):2920-2. Transplant Proc. 1991. PMID: 1721312 No abstract available.
Cited by
-
The effect of FK506 on warm ischemia and reperfusion injury in the rat liver.Surg Today. 1994;24(11):994-1002. doi: 10.1007/BF02215813. Surg Today. 1994. PMID: 7539646
-
Tacrolimus and sirolimus decrease oxidative phosphorylation of isolated rat kidney mitochondria.Br J Pharmacol. 2003 Jan;138(2):369-76. doi: 10.1038/sj.bjp.0705038. Br J Pharmacol. 2003. PMID: 12540528 Free PMC article.
-
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009. Drugs. 1993. PMID: 7506654 Review.